MIB‐1 LI has been extensively used in studies to determine the prognosis of several types of various tumors in central nervous system, including meningiomas, and an elevated MIB‐1 LI has been associated with an increased recurrence rate (Abry et al., 2010). The gene discussed is MIB1; the disease is meningioma.